Drug Type Small molecule drug |
Synonyms BCWP_C003, HCP 1201, HCP-1201 + [4] |
Target |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H28CaFN3O6S |
InChIKeyAVDMILNVMOXCHF-DHMAKVBVSA-N |
CAS Registry147098-20-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 3 | KR | 04 Nov 2015 | |
Dyslipidemias | Phase 3 | KR | 04 Nov 2015 | |
Hyperlipidemias | Phase 1 | KR | 06 Jul 2017 | |
Diabetes Mellitus | Phase 1 | KR | 01 Jun 2013 |